Literature DB >> 3192641

The retention mechanism of technetium-99m-HM-PAO: intracellular reaction with glutathione.

R D Neirinckx1, J F Burke, R C Harrison, A M Forster, A R Andersen, N A Lassen.   

Abstract

Preparations of d,l- and meso-hexamethylpropyleneamine oxime (HM-PAO) labeled with technetium-99m were added to rat brain homogenates diluted with phosphate buffer (1:10). The conversion of d,l-HM-PAO to hydrophilic forms took place with an initial rate constant of 0.12 min-1. Incubation of the brain homogenate with 2% diethyl maleate for 5 h decreased the homogenate's measured glutathione (GSH) concentration from 160 to 16 microM and decreased the conversion rate to 0.012 min-1. Buffered aqueous solutions of glutathione rapidly converted the HM-PAO tracers to hydrophilic forms having the same chromatographic characteristics as found in the brain homogenates. The rate constant for the conversion reaction of d,l-HM-PAO in GSH aqueous solution was 208 and 317 L/mol/min in two different assay systems and for meso-HM-PAO the values were 14.7 and 23.2 L/mol/min, respectively. Rat brain has a GSH concentration of about 2.3 mM and the conversion of the d,l-HM-PAO due to GSH alone should proceed with a rate constant of 0.48 to 0.73 min-1 and be correspondingly 14-fold slower for meso-HM-PAO. In human brain, the in vivo data of Lassen et al. show a conversion rate constant of 0.80 min-1. This correspondence of values supports the notion that GSH may be important for the in vivo conversion of 99mTc-labeled HM-PAO to hydrophilic forms and may be the mechanism of trapping in brain and other cells. A kinetic model for the trapping of d,l- and meso-HM-PAO in tissue is developed that is based on data of GSH concentration in various organs.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3192641     DOI: 10.1038/jcbfm.1988.27

Source DB:  PubMed          Journal:  J Cereb Blood Flow Metab        ISSN: 0271-678X            Impact factor:   6.200


  18 in total

1.  Motor stimulation response by technetium-99m hexamethylpropylene amine oxime split-dose method and single photon emission tomography.

Authors:  P Pantano; V Di Piero; M Ricci; C Fieschi; L Bozzao; G L Lenzi
Journal:  Eur J Nucl Med       Date:  1992

Review 2.  Cerebral blood flow changes in migraine: methods, observations and hypotheses.

Authors:  L Friberg
Journal:  J Neurol       Date:  1991       Impact factor: 4.849

3.  Cerebellar vascular response to acetazolamide in crossed cerebellar diaschisis: a comparison of 99mTc-HMPAO single-photon emission tomography with 15O-H2O positron emission tomography.

Authors:  Y Kuwabara; Y Ichiya; M Sasaki; Y Akashi; T Yoshida; T Fukumura; K Masuda
Journal:  Eur J Nucl Med       Date:  1996-06

4.  Brain single-photon emission CT studies using 99mTc-HMPAO and 99mTc-ECD early after recanalization by local intraarterial thrombolysis in patients with acute embolic middle cerebral artery occlusion.

Authors:  K Ogasawara; A Ogawa; M Ezura; H Konno; M Suzuki; T Yoshimoto
Journal:  AJNR Am J Neuroradiol       Date:  2001-01       Impact factor: 3.825

5.  Role of glutathione in lung retention of 99mTc-hexamethylpropyleneamine oxime in two unique rat models of hyperoxic lung injury.

Authors:  Said H Audi; David L Roerig; Steven T Haworth; Anne V Clough
Journal:  J Appl Physiol (1985)       Date:  2012-05-24

6.  Evaluation of technetium 99m cyclobutylpropylene amine oxime as a potential brain perfusion imaging agent for SPET.

Authors:  L Bacciottini; F Lunghi; A Pupi; C Bonino; A R Formiconi; M T De Cristofaro; A R Petti; U Meldolesi
Journal:  Eur J Nucl Med       Date:  1990

7.  Increased uptake of technetium-99m-hexamethylpropyleneamine oxime related to primary leptomeningeal melanoma.

Authors:  Takao Sagiuchi; Katsumi Ishii; Satoshi Utsuki; Yuuji Asano; Shinya Tsukahara; Shinichi Kan; Kiyotaka Fujii; Kazushige Hayakawa
Journal:  AJNR Am J Neuroradiol       Date:  2002-09       Impact factor: 3.825

8.  99MTc-Hexamethylpropyleneamine Oxime Imaging for Early Detection of Acute Lung Injury in Rats Exposed to Hyperoxia or Lipopolysaccharide Treatment.

Authors:  Said H Audi; Anne V Clough; Steven T Haworth; Meetha Medhora; Mahsa Ranji; John C Densmore; Elizabeth R Jacobs
Journal:  Shock       Date:  2016-10       Impact factor: 3.454

9.  Evaluation of technetium-99m exametazime stabilised with cobalt chloride as a blood flow tracer in focal cerebral ischaemia.

Authors:  G Gartshore; P Bannan; J Patterson; B Higley; J McCulloch
Journal:  Eur J Nucl Med       Date:  1994-09

10.  Functional imaging studies of cognition using 99mTc-HMPAO SPECT: empirical validation using the n-back working memory paradigm.

Authors:  Catherine Ludwig; Christian Chicherio; Luc Terraneo; Pierre Magistretti; Anik de Ribaupierre; Daniel Slosman
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-12-11       Impact factor: 9.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.